Dartmouth-based drug discovery company IMV Inc. said Wednesday that it is making advancements on a possible vaccine for Covid-19.
The company said it will use its DPX delivery platform, which releases drugs in doses over an extended period of time, with the goal of developing a vaccine against the disease that has spread around the globe this year. Vaccines against infectious disease have been a core part of IMV’s mission since the company began in the early years of this century.
The company intends to conduct Phase 1 trials (which assess the safety of a drug) on the vaccine called